Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hoenigl, M; Seidel, D; Carvalho, A; Rudramurthy, SM; Arastehfar, A; Gangneux, JP; Nasir, N; Bonifaz, A; Araiza, J; Klimko, N; Serris, A; Lagrou, K; Meis, JF; Cornely, OA; Perfect, JR; White, PL; Chakrabarti, A, , ECMM, and, ISHAM, collaborators.
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.
Lancet Microbe. 2022; 3(7):e543-e552
Doi: 10.1016/S2666-5247(21)00237-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Hönigl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS-CoV2, which might favour secondary infections. In this Review, we analysed 80 published and unpublished cases of COVID-19-associated mucormycosis. Uncontrolled diabetes, as well as systemic corticosteroid treatment, were present in most patients with COVID-19-associated mucormycosis, and rhino-orbital cerebral mucormycosis was the most frequent disease. Mortality was high at 49%, which was particularly due to patients with pulmonary or disseminated mucormycosis or cerebral involvement. Furthermore, a substantial proportion of patients who survived had life-changing morbidities (eg, loss of vision in 46% of survivors). Our Review indicates that COVID-19-associated mucormycosis is associated with high morbidity and mortality. Diagnosis of pulmonary mucormycosis is particularly challenging, and might be frequently missed in India.
- Find related publications in this database (using NLM MeSH Indexing)
- COVID-19 - complications
- Diabetes Mellitus - epidemiology
- Humans - administration & dosage
- Mucormycosis - complications
- RNA, Viral - administration & dosage
- Risk Factors - administration & dosage
- SARS-CoV-2 - administration & dosage